Pariglasgene Brecaparvovec-opnr Approved for Glycogen Storage Disease 1a
Related coverage: Pariglasgene Brecaparvovec-opnr Approved for Glycogen Storage Disease 1a CGTLive®
Aug 20, 2026
Publisher
The latest headlines and summaries aggregated from CGTLive® on AIMode News.
1 recent stories from CGTLive®
Related coverage: Pariglasgene Brecaparvovec-opnr Approved for Glycogen Storage Disease 1a CGTLive®
Aug 20, 2026
Related coverage: Pariglasgene Brecaparvovec-opnr Approved for Glycogen Storage Disease 1a CGTLive®
CGTLive® ·